Zydus Lifesciences Ltd. (ZYDUSLIFE) - Financials, balance sheet (quarterly)

904.70001 INR

1.2

0.13%

Last update May 15, 3:29 PM IST

Market closed

Day range

904.70001

896.65002

907.45001

Previous close

903.5

Open

903.79999

Access this stock data via API

Zydus Lifesciences Ltd.

904.70

1.20

0.13%

Financials

Balance sheet

Fiscal date	Sep 2024	Mar 2024	Sep 2023	Mar 2023
Total assets	314.5B	292.8B	258.8B	257.6B
Current assets	121.6B	115.0B	99.3B	100.2B
Cash	—	4.1B	—	4.9B
Cash equivalents	—	—	—	—
Cash and cash equivalents	10.6B	4.1B	3.5B	4.9B
Other short term investments	19.3B	9.7B	16.7B	7.2B
Accounts receivable	46.7B	52.2B	39.2B	44.2B
Other receivables	15M	2.7B	24M	1.5B
Inventory	37.2B	34.4B	33.0B	34.1B
Prepaid assets	—	7.2B	—	7.3B
Restricted cash	—	46M	—	48M
Assets held for sale	381M	816M	66M	82M
Hedging assets	—	2.8B	—	0
Other current assets	7.4B	175M	6.9B	186M
Non current assets	192.9B	177.8B	159.4B	157.4B
Properties	61.0B	58.0B	57.2B	57.0B
Land and improvements	—	6.2B	—	6.3B
Machinery furniture equipment	—	80.8B	—	75.0B
Construction in progress	10.5B	11.1B	12.2B	11.3B
Leases	—	—	—	—
Accumulated depreciation	—	-50.8B	—	-45.0B
Goodwill	134.7B	131.4B	106.6B	107.0B
Investment properties	—	—	—	—
Financial assets	—	0	—	1.8B
Intangible assets	29.4B	26.1B	10.5B	10.9B
Investments and advances	—	—	—	—
Other non current assets	2.1B	210M	1.9B	181M
Total liabilities	72.9B	71.8B	49.4B	60.7B
Current liabilities	53.5B	53.4B	43.6B	55.3B
Accounts payable	21.3B	21.3B	16.4B	21.3B
Accrued expenses	—	—	—	—
Short term debt	1.6B	7.8B	1.6B	11.8B
Deferred revenue	—	—	—	—
Tax payable	6.3B	3.7B	5.0B	1.6B
Pensions	—	—	—	—
Other current liabilities	2.8B	396M	2.6B	510M
Non current liabilities	19.4B	18.4B	5.8B	5.4B
Long term provisions	3.7B	3.1B	3.1B	2.7B
Long term debt	315M	251M	307M	198M
Provision for risks and charges	—	—	—	—
Deferred liabilities	4.4B	4.5B	1.8B	1.9B
Derivative product liabilities	—	—	—	—
Other non current liabilities	13M	18M	13M	—
Shareholders equity
Common stock	1.0B	1.0B	1.0B	1.0B
Retained earnings	—	203.7B	—	171.9B
Other shareholders equity	—	—	—	—
Total shareholders equity	241.5B	221.0B	209.4B	196.9B
Additional paid in capital	—	18M	—	12M
Treasury stock	—	—	—	—
Minority interest	23.3B	22.7B	22.1B	21.7B